Related Experiment Video
Updated: Aug 12, 2026
13:05
Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
Fish oil, essential fatty acids, and hypertension
1Smooth Muscle Research Programme, McMaster University, Hamilton, ON, Canada.
Canadian Journal of Physiology and Pharmacology
|August 1, 1994
Summary
Balancing essential fatty acids (EFAs), like omega-3 and omega-6, is crucial for health. While fish oil (n-3 EFAs) shows limited blood pressure reduction and potential risks, n-6 EFAs may be more effective for hypertension, though more research is needed.
Area of Science:
- Nutrition Science
- Cardiovascular Health
- Biochemistry
Background:
- Essential fatty acids (EFAs), specifically n-3 and n-6 series, are vital for human homeostasis and growth.
- Dietary supplementation with n-3 EFAs (fish oil) has been investigated for antihypertensive properties in animal models and humans.
- Existing research indicates potential risks associated with high-dose n-3 EFA supplementation, including effects on glucose control and bleeding time.
Purpose of the Study:
- To evaluate the efficacy and safety of n-3 and n-6 essential fatty acids (EFAs) in managing hypertension.
- To compare the antihypertensive effects of n-3 and n-6 EFAs in animal models and human studies.
- To identify potential risks and benefits associated with EFA supplementation for blood pressure control.
Main Methods:
- Review of animal models investigating the effects of chronic n-3 EFA treatment on hypertension development and hypercholesterolemia.
- Analysis of human studies examining the impact of fish oil (n-3 EFA) supplementation on blood pressure in individuals with borderline and essential hypertension.
- Examination of studies exploring the antihypertensive potential of n-6 EFAs in animal models and limited human trials.
Main Results:
- In animal models, chronic n-3 EFA treatment generally attenuated hypertension development but increased atherosclerosis in hypercholesterolemic animals.
- Human studies showed only a modest reduction in blood pressure with chronic fish oil (n-3 EFA) treatment.
- Animal studies suggest n-6 EFAs may be more effective than n-3 EFAs in lowering blood pressure, potentially via prostaglandin production, but human data is scarce and associated with potential tumor development concerns.
Conclusions:
- While n-3 EFAs offer limited blood pressure reduction and carry risks like impaired glucose control and prolonged bleeding, n-6 EFAs show promise for hypertension management.
- Further research is necessary to elucidate the antihypertensive effects of n-6 EFAs in humans and to thoroughly assess their risk factors, including potential tumor stimulation.
- A comprehensive risk-benefit analysis is required before recommending EFA supplementation for hypertension control in humans.
Related Concept Videos
03:38Structure of Lipids
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...